Suppr超能文献

第三次心脏移植后患者和结局的描述和分析:1985 年至 2017 年美国器官共享网络数据库的分析。

Description and analysis of patients and outcomes following third-time heart transplantation: An analysis of the United Network for Organ Sharing database from 1985 to 2017.

机构信息

Rush University Medical College, Chicago, Illinois.

Department of Cardiovascular and Thoracic Surgery, Rush Medical Center, Chicago, Illinois.

出版信息

Clin Transplant. 2019 Mar;33(3):e13482. doi: 10.1111/ctr.13482. Epub 2019 Feb 8.

Abstract

BACKGROUND

Following second heart transplantation (HTx), some patients experience graft failure and require third-time heart transplantation. Little data exist to guide decision-making with regard to repeat retransplantation in older patients.

METHODS

We performed a retrospective cohort analysis of patients receiving a third HTx, as identified in the United Network for Organ Sharing (UNOS) database from 1985 to 2017.

RESULTS

The study cohort consisted of N = 60 patients, with an average age of 29 with a standard deviation of ±18 years. Overall survival for the cohort at 1, 5, and 10 years is 83%, 64%, and 44%, respectively. The rate of third-time HTxs has steadily increased in all age groups. Patients older than 50 years now account for 18.3% of all third-time HTxs. Although this group demonstrated longer average previous graft survival, after third HTx they demonstrate significantly poorer survival outcomes compared to third-time HTx recipients younger than 21 (P = 0.05). Age over 50, BMI over 30, and diabetes were all found to be independent risk factors for decreased survival following third HTx.

CONCLUSIONS

We describe trends in patients undergoing third HTx. We highlight subsets of such recipients who exhibit decreased survival.

摘要

背景

在接受第二次心脏移植(HTx)后,一些患者会出现移植物衰竭,并需要第三次心脏移植。对于老年患者再次进行重复移植的决策,目前的数据很少。

方法

我们对 1985 年至 2017 年期间在美国器官共享联合网络(UNOS)数据库中确定的接受第三次 HTx 的患者进行了回顾性队列分析。

结果

研究队列包括 60 名患者,平均年龄为 29 岁,标准差为±18 岁。该队列的 1、5 和 10 年总生存率分别为 83%、64%和 44%。所有年龄组的第三次 HTx 率都在稳步上升。目前,50 岁以上的患者占所有第三次 HTx 的 18.3%。尽管该组的平均先前移植物存活率较长,但与 21 岁以下的第三次 HTx 受者相比,他们在第三次 HTx 后的生存结果明显较差(P=0.05)。年龄超过 50 岁、BMI 超过 30 以及糖尿病均被发现是第三次 HTx 后生存率降低的独立危险因素。

结论

我们描述了接受第三次 HTx 的患者的趋势。我们强调了此类受者中生存时间缩短的亚组。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验